Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 0 | 0 | 0 | 21,059 | 30,087 |
| Cost of Goods | 0 | 0 | -26,920 | 8,860 | 9,430 |
| Gross Profit | 0 | 0 | -34,620 | 12,190 | 20,640 |
| Operating Expenses | 8,400 | 8,190 | 4,130 | 10,060 | 11,580 |
| Operating Income | -8,400 | -8,190 | 21,870 | 2,999 | 9,507 |
| Interest Expense | 0 | 1,020 | 980 | 0 | 530 |
| Other Income | 3,160 | 4,910 | -63,180 | 841 | 353 |
| Pre-tax Income | -5,240 | -4,300 | -42,290 | 3,840 | 9,330 |
| Net Income Continuous | -5,249 | -4,304 | -10,596 | 3,842 | 9,330 |
| Net Income Discontinuous | 225 | -52 | 2,353 | 0 | 0 |
| Net Income | $-5,024 | $-4,356 | $-8,243 | $3,842 | $9,330 |
| EPS Basic Total Ops | -900.00 | -800.00 | -2,200.00 | 1,300.00 | 3,700.00 |
| EPS Basic Continuous Ops | -920.88 | -782.55 | -2,863.78 | 1,280.67 | 3,588.46 |
| EPS Basic Discontinuous Ops | 39.47 | -9.45 | 635.95 | N/A | N/A |
| EPS Diluted Total Ops | -900.00 | -800.00 | -2,200.00 | 1,300.00 | 3,700.00 |
| EPS Diluted Continuous Ops | -920.88 | -782.55 | -2,863.78 | 1,280.67 | 3,588.46 |
| EPS Diluted Discontinuous Ops | 39.47 | -9.45 | 635.95 | N/A | N/A |
| EBITDA(a) | $-7,740 | $-8,050 | $61,450 | $-11,681 | $-14,713 |